OVER / UNDER
KXFDAAPPROVALDATENTLA-LONV ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATENTLA-LONV ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATENTLA-LONV ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATENTLA-LONV ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATENTLA-LONV ★ KALSHI ★ MULTI ★ KXFDAAPPROVALDATENTLA-LONV ★ KALSHI ★ MULTI ★

When will the FDA approve Intellia Therapeutics' lonvo-z?

Price history — Before 2028

Last 7 days of market YES price (blue) with the fair-price range (orange).

59¢0¢25¢50¢75¢100¢Sat 5/30Sun 5/31Mon 6/1Tue 6/2Wed 6/3TODAY
market YES fair range
Market price
Before 2028★ BEST59¢
Before October 202741¢
Before July 202726¢
Kalshi • Volume: 1.9K contracts • Updated 3h agoCloses: 2028-01-01
Kalshi · Science and Technology
OU's Pick
YES · Before 2028
at 59¢
Price gap
Kalshi59¢
OU's fair79¢
+20¢ underpriced · pays 1.7×
Confidence
Moderate

Intellia Therapeutics expects to complete its BLA submission in late 2026 and anticipates a potential commercial launch in the first half of 2027 following positive Phase 3 data.

Wide edge+20¢
Not financial advice. For informational purposes only. Prediction markets involve risk of loss. AI may contain errors.